BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9601909)

  • 21. Chromate-allergic patients challenged orally with potassium dichromate.
    Veien NK; Hattel T; Laurberg G
    Contact Dermatitis; 1994 Sep; 31(3):137-9. PubMed ID: 7821003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical expression of nickel contact dermatitis primed by diagnostic patch test.
    Theler B; Bucher C; French LE; Ballmer Weber B; Hofbauer GF
    Dermatology; 2009; 219(1):73-6. PubMed ID: 19349696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late reactions to the patch-test preparations para-phenylenediamine and epoxy resin: a prospective multicentre investigation of the German Contact Dermatitis Research Group.
    Hillen U; Jappe U; Frosch PJ; Becker D; Brasch J; Lilie M; Fuchs T; Kreft B; Pirker C; Geier J;
    Br J Dermatol; 2006 Apr; 154(4):665-70. PubMed ID: 16536809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1- versus 2- and 3-day diagnostic patch testing.
    Manuskiatti W; Maibach HI
    Contact Dermatitis; 1996 Oct; 35(4):197-200. PubMed ID: 8957637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of detergent washing powders on minimal eliciting patch test concentrations of nickel and chromium.
    Allenby CF; Goodwin BF
    Contact Dermatitis; 1983 Nov; 9(6):491-9. PubMed ID: 6418438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tefillin contact dermatitis: a problem in the devout.
    Friedmann AC; Goldsmith P
    Contact Dermatitis; 2008 Sep; 59(3):188-9. PubMed ID: 18759911
    [No Abstract]   [Full Text] [Related]  

  • 27. Trial of 0.5% versus 0.375% potassium dichromate. European Environmental and Contact Dermatitis Research Group (EECDRG).
    Burrows D; Andersen KE; Camarasa JG; Dooms-Goossens A; Ducombs G; Lachapelle JM; Menné T; Rycroft RJ; Wahlberg JE; White IR
    Contact Dermatitis; 1989 Nov; 21(5):351. PubMed ID: 2620518
    [No Abstract]   [Full Text] [Related]  

  • 28. Occupational relevance of positive standard patch-test results in employed persons with an initial report of an occupational skin disease.
    Dickel H; Kuss O; Schmidt A; Diepgen TL
    Int Arch Occup Environ Health; 2002 Aug; 75(6):423-34. PubMed ID: 12070639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic patch testing: the other kind of patch test.
    Jackson EM
    Am J Contact Dermat; 1998 Dec; 9(4):237-9. PubMed ID: 9810026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose per unit area - a study of elicitation of nickel allergy.
    Fischer LA; Menné T; Johansen JD
    Contact Dermatitis; 2007 May; 56(5):255-61. PubMed ID: 17441846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological survey of contact dermatitis in Italy (1984-1993) by GIRDCA (Gruppo Italiano Ricerca Dermatiti da Contatto e Ambientali).
    Sertoli A; Francalanci S; Acciai MC; Gola M
    Am J Contact Dermat; 1999 Mar; 10(1):18-30. PubMed ID: 10072334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patch testing with p-toluene diamine preparations of different ages.
    Geier J; Lessmann H; Schnuch A; Hildebrandt S; Uter W
    Contact Dermatitis; 2005 Aug; 53(2):75-9. PubMed ID: 16033399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interference of the position of substances in an epicutaneous patch test battery with the occurrence of false-positive results.
    Duarte I; Lazzarini R; Buense R
    Am J Contact Dermat; 2002 Sep; 13(3):125-32. PubMed ID: 12165931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patch testing for contact dermatitis.
    Treadgold A
    Nursing (Lond); 1983 Jan; 2(9):255-8. PubMed ID: 6554529
    [No Abstract]   [Full Text] [Related]  

  • 35. Allergic contact dermatitis from iodine preparations: a conundrum.
    Lee SK; Zhai H; Maibach HI
    Contact Dermatitis; 2005 Apr; 52(4):184-7. PubMed ID: 15859989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproducibility of patch test results: a concurrent right-versus-left study using TRUE Test.
    Ale SI; Maibach HI
    Contact Dermatitis; 2004 May; 50(5):304-12. PubMed ID: 15209812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Which children should we patch test?
    Beattie PE; Green C; Lowe G; Lewis-Jones MS
    Clin Exp Dermatol; 2007 Jan; 32(1):6-11. PubMed ID: 17004990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactions of epidermal keratinocytes in sensitized and non-sensitized guinea pigs after dichromate exposure: an electron microscopic study.
    Lindberg M; Forslind B; Wahlberg JE
    Acta Derm Venereol; 1982; 62(5):389-96. PubMed ID: 6183887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patch testing in allergic contact dermatitis.
    Keir J; English J; Fergie N
    J Laryngol Otol; 2009 May; 123(5):558-9. PubMed ID: 19138454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.